Can a Mediterranean diet reduce the effects of lipodystrophy syndrome in people living with HIV? A pilot randomised controlled trial

Sexual Health

Volumn 8, Issue 1, 2011, Pages 43-51

  Ng, Geraldine Wai Bik ^a   Chan, Una Man Shu ^a   Li, Patrick Chung Ki ^a   Wong, William C W ^b  

^a QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

AIDS; body fat; cholesterol; highly active antiretroviral therapy; low fat diet

Indexed keywords

ATAZANAVIR PLUS RITONAVIR; DIDANOSINE; FAT; HIGH DENSITY LIPOPROTEIN; LIPID; LOPINAVIR PLUS RITONAVIR; LOW DENSITY LIPOPROTEIN; NELFINAVIR; OLIVE OIL; STAVUDINE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CLINICAL ARTICLE; DIET RESTRICTION; DIETARY FIBER; DIETETICS; DISEASE CONTROL; FEMALE; FRUIT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED LIPODYSTROPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEGUME; LIPID BLOOD LEVEL; LOW FAT DIET; MALE; MEDITERRANEAN DIET; NUT; RANDOMIZED CONTROLLED TRIAL; SKINFOLD; TRIACYLGLYCEROL BLOOD LEVEL; TRICEPS BRACHII MUSCLE; VEGETABLE; WAIST HIP RATIO; WEIGHT CHANGE;

ADULT; CHOLESTEROL; DIET, FAT-RESTRICTED; DIET, MEDITERRANEAN; FEMALE; HIV INFECTIONS; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 79251624638     PISSN: 14485028     EISSN: None     Source Type: Journal    
DOI: 10.1071/SH09065     Document Type: Article

References (26)

1. Gkrania-Klotsas E, Klotsas A-E. HIV and HIV treatment: effects on fats, glucose and lipids. Br Med Bull 2007;84:49-68. doi:10.1093/bmb/ldm030
2. Purnell J, Zambon A, Knopp RH, Pizzuti DJ, Achari R, Leonard JM, et al. Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects. AIDS 2000;14:51-7. doi:10.1097/00002030-200001070-00006 (Pubitemid 30072077)
3. Saint-Marc T, Partisani M, Poizot-Martin I, Rouviere O, Bruno F, Avellaneda R, et al. Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO* study. AIDS 2000;14:37-49. doi:10.1097/00002030-200001070-00005 (Pubitemid 30072076)
4. Saint-Marc T, Partisani M, Poizot-Martin I, Bruno F, Rouviere O, Lang J, et al. A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy. AIDS 1999;13:1659-67. doi:10.1097/00002030-199909100-00009 (Pubitemid 30015713)
5. Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm D, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998;12: F51-8. doi:10.1097/00002030-199807000-00003 (Pubitemid 28190689)
6. Lo J, Mulligan K, Tai V, Algren H, Schambelan M. "Buffalo hump" in men with HIV-1 infection. Lancet 1998;351:867-70. doi:10.1016/S0140-6736 (97) 11443-X
7. Dong K, Bausserman L, Flynn M, Dickinson BP, Flanigan TP, Mileno MD, et al. Changes in body habitus and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy (HAART). J Acquir Immune Defic Syndr 1999;21:107-13.
8. Dey D, Rotherberg E, Sundh V, Bosaeus I, Steen B. Waist circumference, body mass index and risk for stroke in older people. J Am Geriatr Soc 2002;50:1510-8. doi:10.1046/j.1532-5415.2002.50406.x (Pubitemid 35024643)
9. Dobbelsteyn C, Joffres M, MacLean D, Flowerdew G. A comparative evaluation of waist circumference, waist-to-hip ratio and body mass index as indicators of cardiovascular risk factors. The Canadian Heart Health Surveys. Int J Obes Relat Metab Disord 2001;25:652-61. doi:10.1038/sj.ijo.0801582 (Pubitemid 32417634)
10. Mooser V. Atherosclerosis and HIV in the highly active antiretroviral therapy era: towards an epidemic of cardiovascular disease? AIDS 2003;17(S1): S65-9. doi:10.1097/00002030-200301030-00009 (Pubitemid 36106299)
11. Paton P, Tabib A, Loire R, Tete R. Coronary artery lesions and human immunodeficiency virus infection. Res Virol 1993;144:225-31. doi:10.1016/S0923-2516 (06) 80033-6
12. Navas-Nacher E, Colangelo L, Beam C, Greenland P. Risk factors for coronary heart disease in men aged 18 to 39 years of age. Ann Intern Med 2001;134:433-9.
13. Redman L, Heilbronn L, Martin C, Alfonso A, Smith S, Ravussin E. Effect of calorie restriction with or without exercise on body composition and fat distribution. J Clin Endocrinol Metab 2007;92:865-72. doi:10.1210/jc.2006-2184 (Pubitemid 46465656)
14. National Cholesterol Education Program. Third report of the National Cholesterol Education Program (NCEP) expert panel on: detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Bethesda: National Institutes of Health. National Heart, Lung and Blood Institute; 2001.
15. Grundy S, Denke M. Dietary influences on serum lipids and lipoproteins. J Lipid Res 1990;31:1149-72.
16. Maron D, Fair J, Haskell W. Saturated fat intake and insulin resistance in men with coronary artery disease. Circulation 1991;84:2020-7.
17. Ward K, Sparrow D, Vokonas P, Willett W, Landsberg L, Weiss S. The relationships of abdominal obesity, hyperinsulinemia and saturated fat intake to serum lipid levels: the Normative Aging Study. Int J Obes 1994;18:137-44.
18. Nelson L, Tucker L. Diet composition related to body fat in a multivariate study of 203 men. J Am Diet Assoc 1996;96:771-7. doi:10.1016/S0002-8223 (96) 00215-5
19. Van Horn L, Ballew C, Liu K. Diet, body size and plasma lipidslipoproteins in young adults: differences by race and sex. Am J Epidemiol 1991;133:9-23.
20. Estruch R, Martinez-Gonzales M, Corella D, Salas-Salvadó J, Ruiz-Gutiérrez V, Covas MI, et al. Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med 2006;145:1-11.
21. Willett W, Sacks F, Tribhopoulou A, Drescher G, Ferro-Luzzi A, Helsing E, et al. Mediterranean diet pyramid: a cultural model for healthy eating. Am J Clin Nutr 1995;61: S1402-6.
22. Currier J. How to manage metabolic complications of HIV therapy: what to do while we wait for answers. AIDS Read 2000;109:162-70.
23. Dube M, Sprecher D, Henry WK, Aberg JA, Torriani FJ, Hodis HN, et al. Preliminary guidelines for the evaluation and management of dyslipidemia in HIV-infected adults receiving antiretroviral therapy. Clin Infect Dis 2000;31:1216-24. doi:10.1086/317429 (Pubitemid 32295453)
24. Henry K, Melroe H, Huebesch J, Hermundson J, Simpson J. Atorvastatin and gemfibrozil for protease-inhibitor-related lipid abnormalities. Lancet 1998;352:1031-2. doi:10.1016/S0140-6736 (98) 00022-1
25. Moyle G, Lloyd M, Reynolds B, Baldwin C, Mandalia S, Gazzard B. A randomized open label comparative trial of dietary advice with and without pravastatin for the management of PI associated hypercholesterolaemia. AIDS 2001;15:1503-8. doi:10.1097/00002030-200108170-00007 (Pubitemid 32744597)
26. Morgan-Jones J. An assessment of the nutrition-related needs of people with HIV/AIDS in Sydney. Wollongong: Department of Biomedical Sciences, University of Wollongong; 1998.